Fate Therapeutics (FATE) is developing several small molecules that modulate umbilical-cord stem cells. Reni Benjamin, a biotech analyst at Raymond James Financial, said. The company's shares, which are already up over 40% this year, could head higher in the second half of the year, Benjamin said. "Umbilical cords are being used more and more in bone-marrow transplants, but there are a lot of problems with umbilical cords, including trying to expand these cells and get them to work really well,&q
China will let overseas investors trade its domestic crude futures using the yuan or foreign currencies as it seeks greater influence over prices. The oil contract will be the nation’s first futures product available to foreigners, the State Administration of Foreign Exchange said on its website Friday. Overseas participants can open foreign-exchange settlement accounts used solely for crude trading at designated banks, it said. China, the world’s largest consumer of commodities from energy to
We wrote about and advocated "Sell in May and Go Away". A month and a half later we reversed field back to "Invest the Money". At the time we said that we saw the U.S. economy starting to re-accelerate. It was not immediately evident. We believed we saw the two stalwarts of the recovery, cars and houses, improving further and in the case of cars, maintaining production levels at or near a record. Looking at the U.S. Q2 GDP, it was better than expected. Q1 was revised from being down -0.2% t
While other metals markets continue to be mired in negativity, the price of iron ore surged on Wednesday as the market for the steelmaking raw material in top consumer China show signs of a bottom. The benchmark 62% Fe import price including freight and insurance at the Chinese port of Tianjin raced ahead $3.10 or 5.9% to $53.30 a tonne, capping three days of gains according to data provided by The SteelIndex. The advance in the Metal Bulletin's benchmark 62%-index at the ports of Qingdao-Rizhao-Lianyunga
The best-performing Canadian stocks amid the commodities rout have one thing in common: the mighty U.S. dollar. Earnings estimates compiled by Bloomberg suggest their run will continue. Seven of the top 10 best-performing stocks in the Standard & Poor’s/TSX Composite Index this year report their businesses in U.S. dollars and generate a significant amount of their sales there. This includes the top five-ranked equities: drugmakers Concordia Healthcare Corp. and Valeant Pharmaceuticals International
What has been happening to stocks in China should be put into context. The Q2 GDP came in at +7.0% while estimates averaged +6.8%. Last year the GDP was +7.4%, the worst in 24 years. The bull market exploded after house and property prices had headed down. Corporate and other debt had risen to uncomfortable levels. Neither the economy nor earnings levels would have caused the jump. There was no sudden reform premium for the quality of earnings, no recognition of sustainability or for balance sheet strength (abs
One of the more fanciful notions from the recent rally in iron ore prices is that the steel-making ingredient is now back in a bull market. Asian spot iron ore does meet the techni... Full Story
announced today its financial results for the three and six months ended June 30, 2015. Fred Stanford, President and CEO of Torex said: "With construction currently 80% completed,... Full Story
Some Provinces in Canada had a holiday yesterday. The August holiday mirrors the "Bank Holid... Read More
We wrote about and advocated "Sell in May and Go Away". A month and a half later we rev... Read More
Only really one word changed and we had a pretty smart rally. It was unanimous. No rate change. T... Read More
Interviewee: Lee Buckler, VP Business and Corporate Development Question 1: With the recent an... Read More
NAI500’s President Gilbert Chan recently conducted an interview with Allen Bey, CEO of Rock... Read More
The CEO of Imprimis Pharmaceuticals Mark Baum was recently at Nasdaq Closing Bell Ceremony and wa... Read More
Shanghai Composite Index’s recent plummet and volatility make many Chinese investors terrified and to some extent harm foreign investors. As a matter of fact, in addition to Shangha... Read More
Biogen a buyer or taker? After the recent unsuccessful clinical trial results of its drug candidate aducanumab for Alzheimer’s, Biogen was taken a big hit in the stock ... Read More
Over the past year, the Chinese stock market has been fairly bullish. Taking a look at the weekly Shanghai Composite Index, we can see that the index started its upward path at around 200... Read More
Join us at our GCFF Investment Conference in Toronto! Since the start of the GCFF 15 years ago, hundreds of quality companies with investment opportunities have been introduced to thousan... Event Info
CHINA MINING Congress is hosted by the Chinese Ministry of Land and Resources PRC, with strong participation of the Provincial Departments of the Ministry of Land and Resources and mining... Event Info
Replicel Life Sciences Inc is a clinical stage bio-pharmaceutical company engaged in developing a...
Thunderstruck Resources is a Canadian mining exploration company with highly prospective VMS and ...
MGX is involved in the acquisition and exploration of industrial mineral properties in Western Ca...